Savara, Inc. (SVRA) Financials

SVRA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 177.6 million 37.2 million
2023-09-30 182.1 million 35.5 million
2023-06-30 119.8 million 32.1 million
2023-03-31 129.4 million 31.1 million

SVRA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -15.6 million 1.4 million
2023-09-30 -13.2 million 995000
2023-06-30 -10.5 million 958000
2023-03-31 -12.0 million 864000

SVRA Net Income

No data available :(

SVRA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 162.3 million - 143000
2023-09-30 168.3 million - 139000
2023-06-30 105.2 million - 67000
2023-03-31 114.8 million 26.1 million 65000

SVRA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 179.8 million
2023-09-30 164.3 million
2023-06-30 152.8 million
2023-03-31 152.8 million

SVRA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 24000 12.7 million 4.9 million 34000
2023-09-30 43000 13.9 million 4.1 million -
2023-06-30 225000 8.9 million 3.3 million -
2023-03-31 4000 8.7 million 3.4 million -

SVRA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 66000
2023-09-30 - 63000
2023-06-30 - 24000
2023-03-31 - 23000

SVRA

Price: $4.68

52 week price:
1.69
5.70

Earnings Per Share: -0.33 USD

P/E Ratio: -15.65

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 765007

Ebitda: -6.6 million

Market Capitalization: 700.4 million

Links: